Catherine Poulin-Filion - Profile and Investment Details

Investor Profile

Catherine Poulin-Filion is a Venture Capital, Private Equity Firm, Investment Partner based in Montréal, Quebec, Canada with a diverse investment portfolio that includes companies such as Magnolia Medical Technologies, HighLife, CurvaFix, Aprea, F2G, Atea Pharmaceuticals, Noctrix Health, Inc., EDGe Surgical, Inc., Iantrek Inc, UNUM Therapeutics, Prilenia, Neuros Medical, Inc., Endosense, Cogent Biosciences, BioVex, Simplify Medical, CurvaFix, Inc., Intellia Therapeutics, Miach Orthopaedics, Inc., Checkmate Pharmaceuticals, Apellis Pharmaceuticals, REGENXBIO, Rainier Therapeutics, Pipeline TherapeuticsEffector Therapeutics, Advaxis, Shockwave Medical, RainDance Technologies, Viracta Therapeutics, Cagent Vascular, Neuros Medical, . Over time, Catherine Poulin-Filion has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Catherine Poulin-Filion is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Fundraising, Investment Management, Life Science, Emerging Markets, Portfolio Management, North America-based Startups, Technology, Finance, Biotechnology, Entrepreneurship, Clinical Trials, UK Startups, Medical, Real Estate, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Catherine Poulin-Filion, as their portfolio suggests a familiarity and interest in this area.

Understanding Catherine Poulin-Filion’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.